Integrated emergency medical transportion database and virtual private network system

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Golden Hour Data Systems, Inc. patent solves the following problem:

This invention relates to an integrated system of medical database. More specifically, this invention relates to providing a safe communication and user permission for a medical database of emergency medical transportation industry.

Our analysis of this patent is as follows:

Golden Hour Data Systems, Inc.’s patent US 7668736 B2 deals with Integrated emergency medical transportion database and virtual private network system.
A system and method for providing secure communication of data and user access authority for an integrated emergency medical transportation database. The secure communication and user authority given through a Virtual Private Network (VPN), allowing confidential patient medical records to be transmitted through a public network like the Internet without compromising the confidentiality of the data.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Flame retarded fibers and filaments and process of production therefor

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Albemarle Corporation patent solves the following problem:

Although synthetic fiber materials possess a variety of excellent physical and chemical properties, a common drawback is their ready tendency to burning, so that the synthetic fiber materials traditional subjected to finish treatment for flame retardancy. Examples of finishing treatment methods include dip coating and spray coating. An obvious disadvantage of coatings is that they wear over time.

Our analysis of this patent is as follows:

Albemarle Corporation’s patent US 7666944 B2 deals with Flame retarded fibers and filaments and process of production therefor.
A fiber or filament formed from the mixture comprising (a) at least one fiber-forming thermoplastic polymer and (b) at least one polybrominated anionic styrenic polymer given. The polybrominated anionic styrenic polymer has a bromine content of at least about 50 wt%, and a GPC weight average molecular weight in the range of about 5000 to 40,000, or a GPC magnitude our average molecular weight of at least about 600,000. When the fiber-forming thermoplastic polymer is a polyester, the polybrominated anionic styrenic polymer is present in a flame resistant or flame the amount of retardant. When the fiber-forming thermoplastic polymer is a polyamide, the polybrominated anionic styrenic polymer least about 2 wt% of fibers or filaments. When the fiber-forming thermoplastic polymer is a polyolefin, at least one synergist is present, and the polybrominated anionic styrenic polymer is not greater than 15 wt% of fibers or filaments.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Trans-sialidases obtained from Trypanosoma congolense

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The N.V. Nutricia patent solves the following problem:

Trans-sialidases can transfer sialic acid, preferably alpha-2,3-bonded sialic acids from a donor molecule to an acceptor molecule, which again, alpha-2,3-glycosidic bonds serve as formed, preferably in a -terminal galactose residue.

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 7655784 B2 deals with Trans-sialidases obtained from Trypanosoma congolense.
The invention relates to novel enzymes that transfer sialic acid from a donor molecule to an acceptor molecule (trans-sialidases). The enzyme isolated from the protozoan Trypanosoma congolense. The invention also relates to functional equivalents of said enzymes, nucleic acid sequences and amino acid sequences that code for the enzymes and their functional equivalent, the expression constructs and vector were there said order, the artificial microorganisms that bring creative coding nucleic- acid sequences, a method for artificial production of creative enzyme, to a method for isolating said enzyme from Trypanosoma congolense , to a method for enzymatic sialization acceptor molecules using creative enzyme, the effectors of creative trans-sialidases, the use of nucleic acid sequences, amino acid sequences, enzymes, effectors or sialization products for the production of vaccines, drugs, food or food additives, added to later products obtained in creative ways.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.